Formocortal
![]() | |
| Clinical data | |
|---|---|
| Other names | 3-(2-chloroethoxy)-6-formyl-9α-fluoropregna-3,5-diene-11β,16α,17,21-tetrol-20-one 21-acetate |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C29H38ClFO8 |
| Molar mass | 569.06 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Formocortal (INN), also known as fluoroformylone, is a corticosteroid used in dermatology[1] and ophthalmology.[2]
It was introduced in around 1970[1] and is not known to be marketed as of 2021.
See also
References
- ^ a b Aliperta G, Lattaro R (November 1971). "[On the topical use of a new steroid, formocortal, in the treatment of phlebodermitis and in cutaneous auto- and homo-grafts]". Minerva Cardioangiologica. 19 (11): 620–624. PMID 4942789.
- ^ Marchese A, Bozzolasco M, Gualco L, Schito GC, Debbia EA (2001). "Evaluation of spontaneous contamination of ocular medications". Chemotherapy. 47 (4): 304–308. doi:10.1159/000048538. PMID 11399868. S2CID 33870589.
